Lineage Cell Therapeutics, Inc. reports

Company location: Carlsbad, CA
Fiscal year end: 31 December

Lineage Cell Therapeutics, Inc. has filed 1,802 SEC EDGAR filings since 17 Apr 1996

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 501-525 of 1,000 matching filings.

Per page

Current page

CORRESP

CORRESP filing

Filing date: 27 Jun 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 22 Jun 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 21 Jun 2017
Reporting date: 16 Jun 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

8-K

Filing date: 16 Jun 2017
Reporting date: 15 Jun 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3 File 333-218807

S-3

Filing date: 16 Jun 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

BIOTIME, INC. 8-K

Filing date: 14 Jun 2017
Reporting date: 14 Jun 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 08 Jun 2017
Reporting date: 06 Jun 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 08 Jun 2017
Reporting date: 06 Jun 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

8-K filing

Filing date: 08 Jun 2017
Reporting date: 06 Jun 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 17 May 2017
Reporting date: 16 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

BIOTIME, INC. 8-K

Filing date: 10 May 2017
Reporting date: 10 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-12830

10-Q

Filing date: 10 May 2017
Reporting date: 31 Mar 2017
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

EFFECT File 333-217182

EFFECT filing

Filing date: 05 May 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 03 May 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFA14A File 001-12830

DEFA14A filing

Filing date: 03 May 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3/A File 333-217182

S-3/A

Filing date: 02 May 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 02 May 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 01 May 2017
Reporting date: 10 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 01 May 2017
Reporting date: 10 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-12830

DEF 14A filing

Filing date: 01 May 2017
Reporting date: 27 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 18 Apr 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

8-K

Filing date: 11 Apr 2017
Reporting date: 06 Apr 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3 File 333-217182

BIOTIME, INC S-3 4-6-2017

Filing date: 06 Apr 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-12830

8-K filing

Filing date: 04 Apr 2017
Reporting date: 29 Mar 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

SC 13D/A filing

Filing date: 03 Apr 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing